Sign In
Buy OTIC
$0.0085
+0 (+0%)
At Close: Jul 11, 2023
Why Otonomy's Stock Is Trading Higher Today
02:44pm, Tuesday, 07'th Jul 2020
Otonomy (NASDAQ: OTIC) shares are trading higher on Tuesday.The company reported results from its Phase 1/2 clinical trial of OTO-313 in patients with Tinnitus demonstrated a higher proportion of resp
Otonomy Pops 15% in Pre-Market Fueled By Otividex Data, Positive Results From Tinnitus Candidate
09:51am, Tuesday, 07'th Jul 2020
Shares in Otonomy, Inc. (OTIC) spiked 15% in pre-market trading after the biotech company disclosed statistical data on its vertigo drug Otividex and “positive” trial results from its Tinnitus can
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 6)
ACADIA Pharmaceuticals Inc...
Otonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-313 in Patients with Tinnitus
08:04pm, Monday, 06'th Jul 2020
Otonomy, Inc. (OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced positive top-line results from the Phase 1/2 clinical trial
Otonomy Provides Update on OTIVIDEX® Program
08:02pm, Monday, 06'th Jul 2020
Otonomy, Inc. (OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today provided an update on the statistical analysis plan related to the ong
Were Hedge Funds Right About Piling Into Otonomy Inc (OTIC)?
03:18pm, Tuesday, 30'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
North Energy : Results for the first quarter 2020 | MarketScreener
08:12am, Friday, 19'th Jun 2020Financial Analysis: INmune Bio (NASDAQ:INMB) and Applied Genetic Technologies (NASDAQ:AGTC)
01:48am, Friday, 19'th Jun 2020
INmune Bio (NASDAQ:INMB) and Applied Genetic Technologies (NASDAQ:AGTC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the stre
Cowen & Co. Sticks to Its Buy Rating for Otonomy (OTIC) - Markets
12:47pm, Wednesday, 17'th Jun 2020
In a report issued on June 15, Ken Cacciatore from Cowen & Co. maintained a Buy rating on Otonomy (OTIC
Analysts Are Betting On Otonomy, Inc. (NASDAQ:OTIC) With A Big Upgrade This Week
12:31pm, Wednesday, 17'th Jun 2020
Otonomy, Inc. (NASDAQ:OTIC) shareholders will have a reason to smile today, with the analysts making substantial...
Otonomy (OTIC) Received its Third Buy in a Row - Markets
08:42am, Wednesday, 17'th Jun 2020
After H.C. Wainwright and Oppenheimer gave Otonomy (NASDAQ: OTIC) a Buy rating last month, the company received another Buy, this
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO
12:00am, Tuesday, 16'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 16)
Applied Molecular Transport...
Otonomy Provides Update on Clinical Trials and Development Programs
08:05pm, Monday, 15'th Jun 2020
Otonomy, Inc. (OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today provided an update on its product pipeline and the timeline to results
Otonomy (OTIC) in Focus: Stock Moves 6.1% Higher
12:41pm, Thursday, 11'th Jun 2020
Otonomy (OTIC) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Otonomy to Present at Raymond James 2020 Human Health Innovation Conference
11:30am, Thursday, 11'th Jun 2020
Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A.
